Wedmont Private Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
AAMU
ADEF
BPC
HP
Wedmont Private Capital's BIIB Position: Q2 2026 in Review
Wedmont Private Capital increased its Biogen (BIIB) stake by 3.6% in Q2 2026, buying an estimated $19.9K and bringing the position to 3,012 shares worth $600K. The position accounts for 0.02% of the portfolio, ranked #495.
Wedmont Private Capital first reported a position in BIIB in Q3 2022 and has held it in 16 quarters since. The position peaked at $610K in Q2 2024. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Wedmont Private Capital held 3,012 shares of Biogen worth $600K as of Q2 2026.
- Wedmont Private Capital bought 104 Biogen shares in Q2 2026, an estimated $19.9K.
- Biogen made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #495 holding.
- Wedmont Private Capital first reported a position in Biogen in Q3 2022 and has held it in 16 quarters since.
- Wedmont Private Capital's Biogen position peaked at $610K in Q2 2024.
- 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.